BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3316686)

  • 41. Thallium and gallium scintigraphy in pulmonary Kaposi's sarcoma in an HIV-positive patient.
    Abdel-Dayem H
    Clin Nucl Med; 1995 May; 20(5):473. PubMed ID: 7628162
    [No Abstract]   [Full Text] [Related]  

  • 42. Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma.
    Patz EF; Lowe VJ; Goodman PC; Herndon J
    Chest; 1995 Dec; 108(6):1617-21. PubMed ID: 7497771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gallium scintigraphy in bronchogenic carcinoma. The effect of tumor location on sensitivity and specificity.
    Waxman AD; Julien PJ; Brachman MB; Tanasescu DE; Ramanna L; Birnbaum F; Berman DS; Koerner SK
    Chest; 1984 Aug; 86(2):178-83. PubMed ID: 6589118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [NMR evaluation of neoplastic invasion of the pulmonary artery].
    Tack D; Gevenois PA; Van Sinoy ML; de Francquen P; Rocmans P; Struyven J
    Rofo; 1990 Jan; 152(1):23-9. PubMed ID: 2154004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancer.
    Baum RP; Hellwig D; Mezzetti M
    Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):119-42. PubMed ID: 15243408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diffuse bony uptake of thallium-201-chloride in the granulocyte colony-stimulating factor-producing lung carcinoma.
    Takeuchi R; Kasagi K; Ohta H; Konishi J
    J Nucl Med; 1998 Feb; 39(2):241-3. PubMed ID: 9476927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Staging of non-small cell bronchial carcinoma using CT and MRT].
    Layer G; van Kaick G
    Radiologe; 1990 Apr; 30(4):155-63. PubMed ID: 2160670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thallium and gallium scintigraphy in pulmonary Kaposi's sarcoma in an HIV-positive patient.
    Del val Gómez MA; Castro Beiras JM; Gallardo FG; Verdejo J
    Clin Nucl Med; 1994 May; 19(5):467-8. PubMed ID: 8039330
    [No Abstract]   [Full Text] [Related]  

  • 49. [Peripheral pulmonary neoplasms: combined imaging (computerized tomography, ultrasonography, magnetic resonance) in the evaluation of chest wall involvement].
    Ciccotosto C; Guidotti A; Carriero A; Massari R; Tamburri L; Bonomo L
    Radiol Med; 1993 Nov; 86(5):609-15. PubMed ID: 8272546
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Tumor imaging using 201Tl chloride and 67Ga citrate in nucleomedical surveys].
    Togawa T; Yui N
    Gan To Kagaku Ryoho; 1999 May; 26(6):749-55. PubMed ID: 10410142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gallium-67 scintigraphy and non-small-cell bronchogenic carcinoma: a quantitative in-vivo predictive assay?
    Lentle BC; Catz Z; Dierich HC; Scott JR; Hooper HR
    CMAJ; 1987 Nov; 137(9):815-7. PubMed ID: 2832045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gallium scanning by conventional imaging and emission computed tomography in the pretreatment evaluation of lung cancer.
    Broughton DL; Gibson CJ; Crake T; Pearce SJ; Leonard RC
    Thorax; 1985 Feb; 40(2):96-100. PubMed ID: 3871977
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
    Higashi K; Nishikawa T; Seki H; Oguchi M; Nambu Y; Ueda Y; Yuasa K; Tonami H; Okimura T; Yamamoto I
    J Nucl Med; 1998 Jan; 39(1):9-15. PubMed ID: 9443730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of magnetic resonance imaging in the assessment of patients with lung cancer: a comparison with computed tomography.
    Webb WR
    J Thorac Imaging; 1989 Apr; 4(2):65-75. PubMed ID: 2654410
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical evaluation of 201TI single photon emission computed tomography in patients with large opacities due to silicosis with bronchogenic carcinoma].
    Sunami K; Kishimoto T; Yonei T; Ozaki S; Kimura K; Fujioka H; Ohke M; Ohnoshi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):659-64. PubMed ID: 8741531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nuclear oncology.
    Waxman AD
    Curr Opin Radiol; 1991 Dec; 3(6):871-6. PubMed ID: 1751296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contrast-enhanced MRI for the staging of bronchogenic carcinoma: comparison with CT and histopathologic staging--preliminary results.
    Stiglbauer R; Schurawitzki H; Klepetko W; Kramer J; Schratter M; Tscholakoff D; Eckersberger F
    Clin Radiol; 1991 Nov; 44(5):293-8. PubMed ID: 1760903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evaluation of SPECT with 67Ga and 201Tl in patients with primary lung cancer].
    Tanabe M; Matsuno S; Satoh K; Kawasaki Y; Tamai T; Kojima K; Hino I; Kawase Y; Seo H; Hosokawa N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Nov; 48(11):1445-50. PubMed ID: 3266325
    [No Abstract]   [Full Text] [Related]  

  • 59. Assessment of bolus injection protocol with appropriate concentration for quantitative assessment of pulmonary perfusion by dynamic contrast-enhanced MR imaging.
    Ohno Y; Murase K; Higashino T; Nogami M; Koyama H; Takenaka D; Kawamitu H; Matsumoto S; Hatabu H; Sugimura K
    J Magn Reson Imaging; 2007 Jan; 25(1):55-65. PubMed ID: 17152051
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ACR Appropriateness Criteria® noninvasive clinical staging of bronchogenic carcinoma.
    Ravenel JG; Mohammed TL; Movsas B; Ginsburg ME; Kirsch J; Kong FM; Parker JA; Reddy GP; Rosenzweig KE; Saleh AG;
    J Thorac Imaging; 2010 Nov; 25(4):W107-11. PubMed ID: 21042062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.